Virginia Retirement Systems Et Al G1 Therapeutics, Inc. Transaction History

Virginia Retirement Systems Et Al

  • $10.1 Billion
  • Q3 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Jul 11, 2023
BUY
$2.57 - $8.16 $87,894 - $279,072
34,200 New
34,200 $91,000
Q2 2021

Aug 13, 2021
SELL
$19.57 - $26.32 $232,883 - $313,208
-11,900 Closed
0 $0
Q1 2021

Apr 30, 2021
SELL
$17.58 - $32.59 $467,627 - $866,894
-26,600 Reduced 69.09%
11,900 $286,000
Q4 2020

Feb 16, 2021
BUY
$10.99 - $20.4 $423,115 - $785,400
38,500 New
38,500 $693,000

Others Institutions Holding GTHX

# of Institutions
6
Shares Held
3.55M
Call Options Held
11.7K
Put Options Held
0
View Full List

About G1 Therapeutics, Inc.

GTHX Quotes by TradingView
  • Ticker GTHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,746,800
  • Market Cap $306M
  • Description
  • G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...
More about GTHX
Track This Portfolio

Track Virginia Retirement Systems Et Al Portfolio

Follow Virginia Retirement Systems Et Al and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Virginia Retirement Systems Et Al with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email